New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
How weight loss drugs took over Instagram
In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a pipette filled with the liquid, as if to drop it in her open mouth. “Lose up to 15% of your body weight,” reads the caption on the Instagram post.
New health care policy changes will soon affect weight-loss drugs
Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is promoting innovation within the field and allowing cheaper competitor products to emerge.
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
Can new weight loss drugs fight the US obesity epidemic? Here's what to know
Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?
FDA approves a new weight loss drug, Zepbound from Eli Lilly
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
FDA adds new warning to popular weight loss drugs
The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy.
Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
MONDAY, Nov. 11, 2024 (HealthDay News) -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 ...
Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
Counterfeit weight loss drugs sold online, feeding demand for cheaper options
port director for Customs and Border Protection at New York's JFK Airport. CBP agents are on the front lines, intercepting counterfeit prescription drugs, which pour into the country. These ...
Health on MSN2h
Can This Weight Loss Drug Alleviate Knee Pain? Experts Weigh In
Fact checked by Nick Blackmer A recent study found that semaglutide, a GLP-1 weight loss drug, reduced knee pain in people with obesity and knee osteoarthritis.Experts say the reduced knee pain ...
Clinical trial offers new hope for weight loss seekers
Amid growing concerns over counterfeit weight loss medications, a local clinical trial may offer a safer alternative for ...
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans ...
Reuters on MSN6d
Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdles
Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...